Prolonged Intrathecal Infusion of Thyrotropin Releasing Hormone in Amyotrophic Lateral Sclerosis a
1988; Wiley; Volume: 531; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1988.tb31826.x
ISSN1749-6632
AutoresTheodore L. Munsat, J Taft, David L. Kasdon, Ivor M.D. Jackson,
Tópico(s)Nerve injury and regeneration
ResumoAnnals of the New York Academy of SciencesVolume 531, Issue 1 p. 187-193 Prolonged Intrathecal Infusion of Thyrotropin Releasing Hormone in Amyotrophic Lateral Sclerosisa THEODORE L. MUNSAT, THEODORE L. MUNSAT Neuromuscular Research Unit Tufts-New England Medical Center Boston, Massachusetts 02111Search for more papers by this authorJAMES TAFT, JAMES TAFT Neuromuscular Research Unit Tufts-New England Medical Center Boston, Massachusetts 02111Search for more papers by this authorDAVID KASDON, DAVID KASDON Neuromuscular Research Unit Tufts-New England Medical Center Boston, Massachusetts 02111Search for more papers by this authorIVOR M.D. JACKSON, IVOR M.D. JACKSON Division of Endocrinology Rhode Island Hospital Providence, Rhode IslandSearch for more papers by this author THEODORE L. MUNSAT, THEODORE L. MUNSAT Neuromuscular Research Unit Tufts-New England Medical Center Boston, Massachusetts 02111Search for more papers by this authorJAMES TAFT, JAMES TAFT Neuromuscular Research Unit Tufts-New England Medical Center Boston, Massachusetts 02111Search for more papers by this authorDAVID KASDON, DAVID KASDON Neuromuscular Research Unit Tufts-New England Medical Center Boston, Massachusetts 02111Search for more papers by this authorIVOR M.D. JACKSON, IVOR M.D. JACKSON Division of Endocrinology Rhode Island Hospital Providence, Rhode IslandSearch for more papers by this author First published: June 1988 https://doi.org/10.1111/j.1749-6632.1988.tb31826.xCitations: 12 a Supported by grants from the Muscular Dystrophy Association and by National Institutes of Health Grants GCRC #M01RR00054 and AM34540. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Munsat, T. L. 1984. The motor neuron diseases. In Merritt's Textbook of Neurology. 7th edit. L. P. Rowland, Ed. Lea and Febiger. Philadelphia , PA . 2 Tandan, R. & W. G. Bradley. 1985. Amyotrophic lateral sclerosis. Part 2. Etiopathogenesis. Ann. Neurol. 18: 419–431. 3 Gurney, M. E., S. P. Heinrich, M. R. Lee & H. S. Min. 1986. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 234: 566–574. 4 Gurney, M. E., B. R. Apatoff, G. T. Spear, M. J. Braumel, J. P. Antel, M. Brown-Bania & A. T. Reder. 1986. Neuroleukin: A lymphokine product of lectin-stimulated T cells. Science 234: 574–581. 5 Gurney, M. E. 1984. Suppression of sprouting at the neuromuscular junction by immune sera. Nature 307: 546–548. 6 Gurney, M. E., A. C. Belton, N. Cashman & J. P. Antel. 1984. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N. Engl. J. Med. 311: 933–939. 7 Hauser, S. L., P. A. Cazenave, D. Lyon-Caen, T. Taguchi, M. Huchet, H. Nuret, J. P. Changeux & C. E. Henderson. 1986. Immunoblot analysis of circulating antibodies against muscle proteins in amyotrophic lateral sclerosis and other neurologic diseases. Neurology 36: 1614–1618. 8 Wakata, N., J. Brenner, L. Adelman, J. J. Kelly & T. L. Munsat. 1986. Reinnervation in amyotrophic lateral sclerosis. Neurology 36(Suppl 1): 138. 9 Jeffcoate, S. C., N. White, T. Hokfelt, K. Fuxe & Johansson. 1976. Localization of thyrotropin-releasing hormone in the spinal cord of the rat by immunohistochemistry and radioimmunoassay. J. Endocrinol. 69: 98. 10 Kardon, F. C., A. Winokur & R.D. Utiger. 1977. Thyrotropin-releasing hormone (TRH) in rat spinal cord. Brain Res. 122: 578. 11 Hokfelt, T., K. Fuxe, O. Johansson, S.C. Jeffcoate & N. White. 1975. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunochemistry. Eur. J. Pharmacol. 34: 389. 12 Johansson, O., T. Hokfelt, S. L. Jeffcoate, N. White & L. A. Sternberger. 1980. Ultrastructural localization of TRH-like immunoreactivity. Exp. Brain Res. 38: 1. 13 Lechan, R. M., M. E. Molitch & I. M. D. Jackson. 1983. Distribution of immunoreactive human growth hormone-like material and thyrotropin-releasing hormone in the rat central nervous system: evidence for their coexistence in the same neurons. Endrocrinology 112: 877. 14 Manaker, S., A. Winokur, C. H. Rhodes & T. C. Rainbow. 1985 Autoradiographic localization of thyrotropin-releasing hormone (TRH) receptors in human spinal cord. Neurology 35: 328. 15 Pawowski, L., J. Ruczynaka & E. Przelaninski. 1980. The effect of thyroliberin and some of its analogues on the hind limb flexor reflex in the spinal rat. Pol. J. Pharmacol. Pharm. 32: 539. 16 Ono, H. & Fukuda. 1982. Ventral root depolarization and spinal reflex augmentation by a TRH analog in rat spinal cord. Neuropharmacology 21: 739. 17 Nicoll, R. A. 1978. The action of thyrotropin-releasing hormone substance P and related peptides on frog spinal motoneurons. J. Pharmacol. Exp. Ther. 207: 817. 18 Barbeau, H. & Bedord. 1981. Denervation supersensitivity to 5-OH tryptophane in rats following spinal transections and 5,7 dihydroxytryptamine injection. Neuropharmacology 20: 447. 19 Schmidt-Achert, K. M., V. Askanas & W. K. Engel. 1984. Thyrotropin-releasing hormone enhances choline acetyltransferase and creatine kinase in cultured spinal ventral horn neurons. J. Neurochem. 43: 586–589. 20 Banda, R., E. D. Means, M. Fitzgerald & H. Scherch. 1987. Trophic effects of thyrotropin-releasing hormone on neuronal processes in culture. Neurology 37(Suppl. 1): 285. 21 Banks, R., E. Means & F. J. Samaha. 1985. Trophic effect of thyrotropin-releasing hormone on murine ventral horn neurons in culture. Neurology 35(Suppl. 1): 93. 22 Mailman, R. B., G. D. Frye, R. A. Mueller & G. R. Breese. 1979. Change in brain guanosine–3′, 5′–mono phosphate (c GMP) content by thyrotropin-releasing hormone. J. Pharmacol. Exp. Ther. 208: 169–175. 23 Brooks, B. R., J. Sode, W. K. Engel, et al. 1976. Cyclic nucleotide metabolism in motor neuron disease (ALS complex). Neurology 26: 353. 24 Faden, A. I., T. P. Jacobs, M. T. Smith & J. W. Holaday. 1983. Comparison of thyrotropin-releasing hormone (TRH), naloxone and dexamethasone treatments in experimental spinal injury. Neurology 33: 673. 25 Faden, A. I., T. P. Jacobs & M. T. Smith. 1984. Thyrotropin-releasing hormone in experimental spinal injury: dose response and late treatment. Neurology 34: 1280–1284. 26 Faden, A. I., N. S. Pilotte & D. R. Burt. 1986. Experimental spinal cord injury: Effects of trauma or ischemia on TRH and muscarinic receptors. Neurology 36: 723–726. 27 Sobue, I., H. Yamamoto, M. Konagaya, M. Iida & T. Takayanagi. 1980. Effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration. Lancet 1: 418. 28 Muroga, T., K. Adachi, M. Konagaya, T. Takatanagi & I. Sobue. 1982. Effects of thyrotropin-releasing hormone on cerebellar mutant miceA kinesiological comparison between rolling mouse Nagoya, weaver and reeler. Jap. J. Med. 21: 101. 29 Banda, R. W., E. D. Means & M. Fitzgerald. 1987. Thyrotropin-releasing hormone decreases neuronal loss induced by axotomy in infant rats. Neurology 37(Suppl. 1): 285. 30 Mitsuma, T., T. Nogumou, K. Adachi, M. Mukoyama & K. Ando 1984. Concentrations of immunoreactive thyrotropin-releasing hormone in spinal cord of patients with amyotrophic lateral sclerosis. Am. J. Med. Soc. 287: 34–36. 31 Jackson, I. M. D., T. L. Munsat, J. Taft, R. Lechan & L. Adelman. 1985. TRH is normal in ALS spinal cord but cyclic his-pro DKP is elevated. Neurology 35(Suppl. 1): 106. 32 Brooks, B. R., J. Turner, T. Schwartz, H. Hartmann & W. Tourtellotte. 1987. Human spinal thyrotropin-releasing hormone (TRH) metabolism: Increased TRH catabolism with histidyl proline (his-pro OH) and proline formation in amyotrophic lateral sclerosis (ALS) patients. Neurology 37(Suppl. 1): 163. 33 Schwartz, T. M., J. G. Turner & B. R. Brooks. 1986. Thyrotropin-releasing hormone (TRH) degradation in NIH:N mouse cerebral cortex and spinal cord. Neurosci. Lett. 71: 209–212. 34 Engel, W. G., T. Siddique & J. Nicoloff. 1983. Effects on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet 1: 73. 35 Mitsumoto, H., E. D. Salgado, D. Negroski, et al. 1986. Amyotrophic lateral sclerosis: Effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials. Neurology 36: 152–159. 36 Brooke, M. H., J. M. Florence, S. L. Heller, et al. 1986. Controlled trial of thyrotropin-releasing hormone in amyotrophic lateral sclerosis. Neurology 36: 146–151. 37 Caroscio, J. T., J. A. Cohen, J. Zawodniak, et al. 1986. A double-blind, placebocontrolled trial of TRH in amyotrophic lateral sclerosis. Neurology 36: 141–145. 38 Munsat, T. L., J. Taft & D. Kasdon. 1987. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis. Neurol. Clin. 5: 159–170. 39 Munsat, T. L., J. Taft & I. M. D. Jackson. 1987. Pharmacokinetics of intrathecal thyrotropin-releasing hormone. Neurology 37: 597–601. 40 Kaplan, M. M., J. M. Taft, S. Reichlin & T. L. Munsat. 1987. Sustained rises in serum thyrotropin, thyroxine and triiodothyromine during long-term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. J. Clin. Endocrinol. Metab. 63: 808–814. 41 Povasuthipaiset, K., R. C. Norman, W. E. Ellinwood, T. T. Oyama, W. C. Baughman & H. G. Spies. 1983. Different prolactin, thyrotropin and thyroxine responses after prolonged intermittant or continuous infusions of thyrotropin-releasing hormone in Rhesus monkeys. J. Clin. Endocrinol. 56: 541. 42 White, S. R. 1985. A comparison of the effects of serotonin, substance P and thyrotropin-releasing hormone on excitability of rat spinal motoneurons in vivo. Brain Res. 335: 63–70. Citing Literature Volume531, Issue1Neurological Applications of Implanted Drug PumpsJune 1988Pages 187-193 ReferencesRelatedInformation
Referência(s)